TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Longo, F. [1 ]
Pellegrini, P. [1 ]
Ceccarelli, F. [1 ]
Borgomastro, A. [1 ]
Comito, T. [1 ]
Basile, M. L. [1 ]
De Biasio, G. [2 ]
Girolami, M. [2 ]
Spalletta, B. [1 ]
Di Seri, M. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[2] Univ Roma La Sapienza, Dept Surg 4, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
    Schwonzen, M
    Kurbacher, CM
    Mallmann, P
    [J]. ANTI-CANCER DRUGS, 2000, 11 (09) : 681 - 685
  • [2] Toxicity of weekly liposomial doxorubicin and paclitaxel in metastatic breast cancer (MBC): 24 months update
    Di Seri, M.
    Girolami, M.
    Rosati, M. S.
    Basile, M. L.
    Ricciardi, S.
    Messina, C. G. M.
    Pellegrini, P.
    Tomao, F.
    De Biasio, L.
    Longo, F.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 15 - 15
  • [3] PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)
    Badalamenti, Giuseppe
    Valerio, Maria Rosaria
    Rinaldi, Gaetana
    Arcara, Carlo
    Cicero, Giuseppe
    Vizzini, Laura
    Travagliato, Maria Grazia
    Intrivici, Chiara
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [4] Weekly paclitaxel and pegylated liposomal doxorubicin in metastatic breast carcinoma
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Usset, A.
    Savio, G.
    Laudani, A.
    Calabria, C.
    Tartaglia, L.
    Amari, P.
    Carruba, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 55 - 55
  • [5] Weekly paclitaxel (T) and pegylated liposomal doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.
    Fulfaro, F
    Valerio, MR
    Badalamenti, G
    Arcara, C
    Cicero, G
    Intrivici, C
    Crosta, A
    Sciortino, C
    Russo, A
    Gebbia, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [6] Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel as first line therapy in metastatic breast cancer
    Fulfaro, F.
    Valerio, M. R.
    Cicero, G.
    Rinaldi, G.
    Intrivici, C.
    Pizzo, T.
    Crosta, A.
    Scibilia, C.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI10 - XI11
  • [7] Bi-weekly administration of pegylated liposomal doxorubicin plus paclitaxel in metastatic breast cancer (MBC) patients: A phase II study.
    Simoncini, E
    Ferrari, VD
    Amoroso, V
    Valcamonico, F
    Grisanti, S
    Vassalli, L
    Marpicati, P
    Montini, E
    Rangoni, G
    Marini, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 88S - 88S
  • [8] A phase II study of bi-weekly pegylated liposomal doxorubicin and paclitaxel in metastatic breast canecer (MBC) patients (pts)
    Ferrari, Vittori D.
    Simoncini, Edda
    Amoroso, Vito
    Grisanti, Salvatore
    Valcamonico, Francesca
    Vassalli, Lucia
    Marpicati, Patrizia
    Rangoni, Giovanni
    Marini, Giovanni
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 49 - 49
  • [9] Renal toxicity with liposomal doxorubicin in metastatic breast cancer
    Yemm, Kristyn E.
    Alwan, Laura M.
    Malik, A. Bilal
    Salazar, Lupe G.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (07) : 1738 - 1742
  • [10] Weekly paclitaxel and pegylated liposomal doxorubicin (PLD) as first-line therapy in metastatic breast cancer
    Valerio, M. R.
    Fulfaro, F.
    Cicero, G.
    Rinaldi, G.
    Maiorana, O.
    Spinnato, F.
    Intrivici, C.
    Crosta, A.
    Scibilia, C.
    Pizzo, T.
    Vanella, P.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII147 - VII147
12345